Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models
There are exciting new advances in multiple sclerosis (MS) resulting in a growing understanding of both the complexity of the disorder and the relative involvement of grey matter, white matter and inflammation. Increasing need for preclinical imaging is anticipated, as animal models provide insights...
Main Authors: | Nabeela Nathoo, V. Wee Yong, Jeff F. Dunn |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | NeuroImage: Clinical |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158214000552 |
Similar Items
-
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
by: Jordan R. Warford, et al.
Published: (2018-01-01) -
Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014–2019
by: Bridget Martinez, et al.
Published: (2020-01-01) -
What Guides Peripheral Immune Cells into the Central Nervous System?
by: Theresa Greiner, et al.
Published: (2021-08-01) -
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
by: M. Mecha, et al.
Published: (2013-11-01) -
Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease
by: Shinji Yamamoto, et al.
Published: (2017-07-01)